NOVARTIS AG - Ordinary Shares (NVS)

CUSIP: 66987V109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Ordinary Shares
Shares outstanding
2,181,288,547
Total 13F shares
199,549,854
Share change
-5,784,145
Total reported value
$16,868,395,196
Put/Call ratio
62%
Price per share
$84.53
Number of holders
1,132
Value change
-$491,947,942
Number of buys
420
Number of sells
515

Quarterly Holders Quick Answers

What is CUSIP 66987V109?
CUSIP 66987V109 identifies NVS - NOVARTIS AG - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2022

As of 30 Jun 2022, NOVARTIS AG - Ordinary Shares (NVS) was held by 1,132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 199,549,854 shares. The largest 10 holders included Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, Fisher Asset Management, LLC, FRANKLIN RESOURCES INC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, and Boston Partners. This page lists 1,132 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.